These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16110508)

  • 1. Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.
    Chen Z; Maricic M; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS; Bassford TL
    Cancer; 2005 Oct; 104(7):1520-30. PubMed ID: 16110508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.
    Ribom EL; Ljunggren O; Mallmin H
    J Clin Densitom; 2008; 11(3):404-11. PubMed ID: 18280191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of parity on bone mineral density among postmenopausal Saudi Arabian women.
    Sadat-Ali M; Al-Habdan I; Al-Mulhim AA; El-Hassan AY
    Saudi Med J; 2005 Oct; 26(10):1588-90. PubMed ID: 16228061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal breast cancer survivors at risk for osteoporosis: physical activity, vigor, and vitality.
    Gross GJ; Ott CD; Lindsey AM; Twiss JJ; Waltman N
    Oncol Nurs Forum; 2002 Oct; 29(9):1295-300. PubMed ID: 12370699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus.
    Al-Maatouq MA; El-Desouki MI; Othman SA; Mattar EH; Babay ZA; Addar M
    Saudi Med J; 2004 Oct; 25(10):1423-7. PubMed ID: 15494815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coeliac disease-specific tissue transglutaminase autoantibodies are associated with osteoporosis and related fractures in middle-aged women.
    Agardh D; Björck S; Agardh CD; Lidfeldt J
    Scand J Gastroenterol; 2009; 44(5):571-8. PubMed ID: 19255929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
    Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
    Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.
    Patel R; Blake GM; Fogelman I
    Calcif Tissue Int; 2007 Feb; 80(2):89-96. PubMed ID: 17308990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
    Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of osteoporosis in Thai men.
    Pongchaiyakul C; Apinyanurag C; Soontrapa S; Soontrapa S; Pongchaiyakul C; Nguyen TV; Rajatanavin R
    J Med Assoc Thai; 2006 Feb; 89(2):160-9. PubMed ID: 16579001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between low lean body mass and osteoporotic fractures after menopause.
    Capozza RF; Cure-Cure C; Cointry GR; Meta M; Cure P; Rittweger J; Ferretti JL
    Menopause; 2008; 15(5):905-13. PubMed ID: 18520697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance.
    Mann GB; Kang YC; Brand C; Ebeling PR; Miller JA
    J Clin Oncol; 2009 Aug; 27(22):3605-10. PubMed ID: 19546403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry.
    Sedrine WB; Chevallier T; Zegels B; Kvasz A; Micheletti MC; Gelas B; Reginster JY
    Gynecol Endocrinol; 2002 Jun; 16(3):245-50. PubMed ID: 12192897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between the age of menarche, menopause and other factors and postmenopause osteoporosis].
    Li HL; Zhu HM
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):796-8. PubMed ID: 16412321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma.
    Brown JE; Ellis SP; Silcocks P; Blumsohn A; Gutcher SA; Radstone C; Hancock BW; Hatton MQ; Coleman RE
    Clin Cancer Res; 2006 Nov; 12(21):6480-6. PubMed ID: 17085662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors.
    Cauley JA; Song J; Dowsett SA; Mershon JL; Cummings SR
    Breast Cancer Res Treat; 2007 Apr; 102(2):181-8. PubMed ID: 17028986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in breast cancer patients with positive estrogen receptor tumor status.
    Douchi T; Yonehara Y; Kosha S; Iwamoto I; Rai Y; Sagara Y; Umekita Y
    Maturitas; 2007 Jul; 57(3):221-5. PubMed ID: 17240090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
    Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.